BackGinkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) Overview

Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) Current Cash

Track Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s current cash ($85M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$84.53M
58.47% YoYΔ $-119.03M vs prior year quarter

Peer trimmed avg / median

Loading

Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) Current Cash History

Loading

Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) vs. peers: Current Cash Comparison

Loading

Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) (SRNGU) FAQ

Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s current cash stands at $85M as of June 2026. That compares with $200M in the prior-year period — down 58.5% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War) reported $85M in current cash versus $200M a year earlier — a 58.5% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $200M in the prior-year period — down 58.5% year over year. Sustained growth in current cash can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s current cash evolved across reporting periods, while the comparison chart places SRNGU next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, current cash is commonly used to spot outliers. Ginkgo Bioworks Holdings- Units (1 Ord Share Class A & 1/5 War)'s reading of $85M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.